NGLY1 Deficiency, a Congenital Disorder of Deglycosylation: From Disease Gene Function to Pathophysiology. [PDF]
Pandey A +3 more
europepmc +1 more source
Reversibility of motor dysfunction in the rat model of NGLY1 deficiency. [PDF]
Asahina M +5 more
europepmc +1 more source
Correction to: Reversibility of motor dysfunction in the rat model of NGLY1 deficiency. [PDF]
Asahina M +5 more
europepmc +1 more source
An in vivo drug repurposing screen and transcriptional analyses reveals the serotonin pathway and GSK3 as major therapeutic targets for NGLY1 deficiency. [PDF]
Hope KA +3 more
europepmc +1 more source
JF1/B6F1 Ngly1-/- mouse as an isogenic animal model of NGLY1 deficiency. [PDF]
Asahina M +6 more
europepmc +1 more source
A Drosophila screen identifies NKCC1 as a modifier of NGLY1 deficiency. [PDF]
Talsness DM +11 more
europepmc +1 more source
A conserved role for AMP-activated protein kinase in NGLY1 deficiency. [PDF]
Han SY +6 more
europepmc +1 more source
NGLY1 deficiency: Novel patient, review of the literature and diagnostic algorithm. [PDF]
Lipiński P +4 more
europepmc +1 more source
Natural history of NGLY1 deficiency: motor function & clinical features. [PDF]
Morrison G +9 more
europepmc +1 more source
The STING pathway drives noninflammatory neurodegeneration in NGLY1 deficiency. [PDF]
Yang K +15 more
europepmc +1 more source

